Global Hematology Diagnostics Market Introduction and Overview
According to SPER Market Research, the Global Hematology Diagnostics Market is estimated to reach USD 17.68 billion by 2033 with a CAGR of 4.64%.
The report includes an in-depth analysis of the Global Hematology Diagnostics Market, including market size and trends, product mix, applications, and supplier analysis. Hematological diagnostics is a branch of medical diagnostics that looks at and analyzes blood and its constituent parts to identify and monitor a number of blood conditions, such as immune system diseases, coagulation disorders, anemia, and leukemia. It involves a wide range of laboratory procedures and tests to assess the makeup and functionality of blood, including hemoglobin, platelets, white blood cells, red blood cells, and hemoglobin, among other parameters, in order to inform treatment choices, monitor the course of the disease, and guarantee the general health of the patient. Hematological diagnostics are essential for revealing vital information about a patient's hematopoietic condition and are used in both clinical and research settings.
- Nihon Kohden introduced the MEK-1305 Celltac α+, an automated hematology and ESR analyzer, to the international market in December 2020. The Meyk1305 is a cutting-edge hematological analyzer that can measure ESR and a complete blood count, which includes a three-part white blood cell differential.
- HORIBA announced in June 2024 the release of the Yumizen H550E, H500E CT, and H500E OT, new compact hematology analyzers with combined CBC/Diff and ESR (erythrocyte sedimentation rate) testing capabilities. The CoRA (Correlated Rouleaux Analysis) technology, which these analyzers employ, provides quick and thorough findings along with cancer and infectious disease screening capabilities.
Market Opportunities and Challenges
Opportunities- The market for hematology diagnostics is expected to develop as a result of rising awareness of health and screening initiatives, the prevalence of chronic illnesses, and the widespread use of point-of-care testing. In May 2023, the World Health Organization (WHO) reported that anemia affects 40% of all children aged 6 to 59 months, 37% of pregnant women, and 30% of women aged 15 to 49 worldwide. Furthermore, Demand has also grown dramatically as a result of technological developments in diagnostic tools and procedures. Hematology tests are becoming more accurate, efficient, and wide-ranging because to innovations like automated analyzers, flow cytometry, and molecular diagnostics. The acceptance of these technologies is further fueled by the ease with which healthcare providers can now diagnose complex illnesses and customize therapies for each patient. Furthermore, regular health examinations and preventive healthcare are becoming more and more important. Hematology tests are being used more frequently to track overall health and identify possible problems early on as a result of this change in healthcare practices. Regular screenings are also encouraged by public health programs and awareness efforts, which adds to the overall rise in demand.
Challenges- However, the market expansion for hematological diagnostics may be significantly hampered by a shortage of qualified personnel. One of the biggest barriers to social advancement and economic success in developing nations is the lack of trained workers. Lack of access to excellent medical care can result in higher mortality rates, less effective treatment outcomes, and a deficit of critical health services in the health sector. This is caused by a paucity of competent physicians, lab technicians, and other healthcare workers.
Market Competitive Landscape
The Global Hematology Diagnostics Market is highly consolidated. Some of the market key players are Abbott Laboratories, Cardinal Health Inc., Danaher Corporation, EKF Diagnostics Holdings plc, Erba Mannheim, F. Hoffmann-La Roche Ltd., Nihon Kohden Corporation, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens AG, Sysmex Corporation.
Scope of the report:
| Report Metric | Details |
| Market size available for years | 2020-2033 |
| Base year considered | 2023 |
| Forecast period | 2024-2033 |
| Segments covered | By Product, By Test Type, By End User |
| Regions covered | North America, Asia-Pacific, Latin America, Middle East & Africa and Europe |
| Companies Covered | Abbott Laboratories, Cardinal Health Inc., Danaher Corporation, EKF Diagnostics Holdings plc, Erba Mannheim, F. Hoffmann-La Roche Ltd., Nihon Kohden Corporation, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens AG, Sysmex Corporation. |
COVID-19 Impact on Global Hematology Diagnostics Market
The COVID-19 pandemic had a major impact on the global market for hematological diagnostics in a number of ways. The need for thorough testing increased as hematological evaluations became crucial for tracking COVID-19 patients' health and assessing how well they were responding to treatment. But the crisis also disrupted the supply chain, resulting in shortages of equipment, testing kits, and essential reagents, which impacted market availability. Furthermore, regular diagnostic procedures were delayed or cut back as healthcare resources were directed toward addressing COVID-19 cases.
Key Target Audience:
- Healthcare Providers
- Clinical Laboratories
- Hospitals and Healthcare Institutions
- Diagnostic Device Manufacturers
- Pharmaceutical Companies
- Research and Academic Institutions
- Government Health Agencies
- Patients and Patient Advocacy Groups
Our in-depth analysis of the Global Hematology Diagnostics Market includes the following segments:
|
By Product:
|
Instrument
Analyzers
Flow cytometers
Others
Consumables
Analyzers
Flow cytometers
Others
|
|
By Test Type:
|
Blood count
Platelet function
Hemoglobin
Hematocrit
|
|
By End User:
|
Hospitals
Diagnostic labs
Others
|
Key Topics Covered in the Report:
- Global Hematology Diagnostics Market Size (FY’2024-FY’2033)
- Overview of Global Hematology Diagnostics Market
- Segmentation of Global Hematology Diagnostics Market By Product (Instrument, Consumables)
- Segmentation of Global Hematology Diagnostics Market By Test Type (Blood Count, Platelet Function, Hemoglobin, Hematocrit)
- Segmentation of Global Hematology Diagnostics Market By End User (Hospitals, Diagnostic labs, Others)
- Statistical Snap of Global Hematology Diagnostics Market
- Expansion Analysis of Global Hematology Diagnostics Market
- Problems and Obstacles in Global Hematology Diagnostics Market
- Competitive Landscape in the Global Hematology Diagnostics Market
- Impact of COVID-19 and Demonetization on Global Hematology Diagnostics Market
- Details on Current Investment in Global Hematology Diagnostics Market
- Competitive Analysis of Global Hematology Diagnostics Market
- Prominent Players in the Global Hematology Diagnostics Market
- SWOT Analysis of Global Hematology Diagnostics Market
- Global Hematology Diagnostics Market Future Outlook and Projections (FY’2024-FY’2033)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPER’s internal database
2.1.4. Premium insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. COVID-19 Impacts of the Global Hematology Diagnostics Market.
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTER’s Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Hematology Diagnostics Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Hematology Diagnostics Market
7. Global Hematology Diagnostics Market, By Product (USD Million) 2020-2033
7.1. Global Hematology Diagnostics Market Size, Share and Forecast, By Product, 2020-2026
7.2. Global Hematology Diagnostics Market Size, Share and Forecast, By Product, 2027-2033
7.3. Instrument
7.3.1. Analyzers
7.3.2. Flow cytometers
7.3.3. Others
7.4. Consumables
7.4.1. Analyzers
7.4.2. Flow cytometers
7.4.3. Others
8. Global Hematology Diagnostics Market, By Test Type (USD Million) 2020-2033
8.1. Global Hematology Diagnostics Market Size, Share and Forecast, By Test Type, 2020-2026
8.2. Global Hematology Diagnostics Market Size, Share and Forecast, By Test Type, 2027-2033
8.3. Blood count
8.4. Platelet function
8.5. Hemoglobin
8.6. Hematocrit
9. Global Hematology Diagnostics Market, By End User (USD Million) 2020-2033
9.1. Global Hematology Diagnostics Market Size, Share and Forecast, By End User, 2020-2026
9.2. Global Hematology Diagnostics Market Size, Share and Forecast, By End User, 2027-2033
9.3. Hospitals
9.4. Diagnostic labs
9.5. Others
10. Global Hematology Diagnostics Market Forecast, 2020-2033 (USD Million)
10.1. Global Hematology Diagnostics Market Size and Market Share
11. Global Hematology Diagnostics Market, By Region, 2020-2033 (USD Million)
11.1. Global Hematology Diagnostics Market Size and Market Share By Region (2020-2026)
11.2. Global Hematology Diagnostics Market Size and Market Share By Region (2027-2033)
11.3. Asia-Pacific
11.3.1. Australia
11.3.2. China
11.3.3. India
11.3.4. Japan
11.3.5. South Korea
11.3.6. Rest of Asia-Pacific
11.4. Europe
11.4.1. France
11.4.2. Germany
11.4.3. Italy
11.4.4. Spain
11.4.5. United Kingdom
11.4.6. Rest of Europe
11.5. Middle East and Africa
11.5.1. Kingdom of Saudi Arabia
11.5.2. United Arab Emirates
11.5.3. Qatar
11.5.4. South Africa
11.5.5. Egypt
11.5.6. Morocco
11.5.7. Nigeria
11.5.8. Rest of Middle-East and Africa
11.6. North America
11.6.1. Canada
11.6.2. Mexico
11.6.3. United States
11.7. Latin America
11.7.1. Argentina
11.7.2. Brazil
11.7.3. Rest of Latin America
12. Company Profile
12.1. Abbott Laboratories
12.1.1. Company details
12.1.2. Financial outlook
12.1.3. Product summary
12.1.4. Recent developments
12.2. Cardinal Health Inc.
12.2.1. Company details
12.2.2. Financial outlook
12.2.3. Product summary
12.2.4. Recent developments
12.3. Danaher Corporation
12.3.1. Company details
12.3.2. Financial outlook
12.3.3. Product summary
12.3.4. Recent developments
12.4. EKF Diagnostics Holdings plc
12.4.1. Company details
12.4.2. Financial outlook
12.4.3. Product summary
12.4.4. Recent developments
12.5. Erba Mannheim
12.5.1. Company details
12.5.2. Financial outlook
12.5.3. Product summary
12.5.4. Recent developments
12.6. F. Hoffmann-La Roche Ltd.
12.6.1. Company details
12.6.2. Financial outlook
12.6.3. Product summary
12.6.4. Recent developments
12.7. Nihon Kohden Corporation
12.7.1. Company details
12.7.2. Financial outlook
12.7.3. Product summary
12.7.4. Recent developments
12.8. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
12.8.1. Company details
12.8.2. Financial outlook
12.8.3. Product summary
12.8.4. Recent developments
12.9. Siemens AG
12.9.1. Company details
12.9.2. Financial outlook
12.9.3. Product summary
12.9.4. Recent developments
12.10. Sysmex Corporation
12.10.1. Company details
12.10.2. Financial outlook
12.10.3. Product summary
12.10.4. Recent developments
12.11. Others
13. Conclusion
14. List of Abbreviations
15. Reference Links